Cat. No.: |
CXCL1-162H |
Product Overview: |
Recombinant CXCL1 protein was expressed in E.coli and purified by using conventional chromatography techniques, 52591,6 Da (481aa). |
Description: |
CXCL1 is secreted by human melanoma cells, has mitogenic properties and is implicated in melanoma pathogenesis. CXCL1 is expressed by macrophages, neutrophils and epithelial cells, and has neutrophil chemoattractant activity. CXCL1 plays a role in spinal cord development by inhibiting the migration of oligodendrocyte precursors and is involved in the processes of angiogenesis, inflammation, wound healing, and tumorigenesis. This chemokine elicits its effects by signaling through the chemokine receptor CXCR2. The gene for CXCL1 is located on human chromosome 4 amongst genes for other CXC chemokines. An initial study in mice showed evidence that CXCL1 decreased the severity of multiple sclerosis and may offer a neuro-protective function. |
Sequences of amino acids: |
MARAALSAAP SNPRLLRVAL LLLLLVAAGR RAAGASVATE LRCQCLQTLQ GIHPKNIQSV NVKSPGPHCA QTEVIATLKN GRKACLNPAS PIVKKIIEKM LNSDKSN |
Formulation: |
Supplied in phosphate buffered saline (PBS) and 30% glycerol, pH 7.4 and contains not preservatives. |
Applications: |
ELISA; WB; Antibody Production; Protein array |
Testing protocols: |
10% SDS-PAGE stained with Coomassie Blue (CB), immunobloting with anti-MBP (WB) and peptide fingerprinting by MALDI-TOF mass spectrometry |